RAPT RAPT Therapeutics Inc. Full Business Value
RAPT Therapeutics, Inc. (RAPT) maintains its headquarters and research centers in California, where process reliability is ensured through equipment redundancy and autonomous power supplies. The environmental profile is limited to standard chemical disposal controls and energy conservation. This price chart on GURU.Markets, serving as confirmation of the market valuation, captures the enterprise value at 1452.99. RAPT Therapeutics, Inc. (RAPT) minimizes risks by utilizing small molecule discovery to develop treatments for cancer and inflammation.
RAPT Therapeutics, Inc. (RAPT) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:RAPT Therapeutics Inc. (RAPT)
Enterprise Value (EV) represents the total acquisition price of a business, combining market capitalization and net debt. By analyzing the chart value of the enterprise, an investor sees the actual cost of acquiring RAPT Therapeutics, Inc. (RAPT) while accounting for its liquid reserves. For the biopharmaceutical sector, this indicator is critical, as it reflects the company's ability to fund clinical trials using available cash without excessive borrowing.
Competitor analysis for RAPT Therapeutics, Inc.
argenx N.V. - Enterprise Value|Total Company Value BioNTech Group|Abivax Pharma (ABVX) - Full Business Value|ADMA - Real Price to Acquire Entire Company|PTGX (protagonist-inc.com) - Aggregate Business Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Astria Therapeutics Inc - Total Enterprise Value|Total Company Value enGene Bio (ENGN)|JBIO - Value Adjusted for Debt and Cash|ACRS: Enterprise Value|KYTX (kyvernatx.com) - Enterprise Value|Total Company Value Tiziana Life Sciences Ltd TLSA|Full Business Value Cabaletta Bio Inc. (CABA)|Real Price to Acquire Entire Company Ventyx Bio|Aggregate Business Value Theratechnologies, Inc THTX|Real Price to Acquire Entire Company Avalo Therapeutics, Inc|ELDN - Value Adjusted for Debt and Cash|Real Price to Acquire Entire Company Agenus Inc. AGEN|CLYM - Aggregate Business Value|Enterprise Value Zura Bio ZURA|aTyr Pharmaceuticals (ATYR) - Value Adjusted for Debt and Cash|Enterprise Value ADAG (Adagene Inc)|Total Enterprise Value IMA|Shattuck Labs, Inc. (STTK) - Total Company Value|Value Adjusted for Debt and Cash equilliumbio.com (EQ)|Enterprise Value CNTB (Connect Biopharma Holdings Limited)|Immunic Therapeutics - Enterprise Value|Total Company Value Atara Biotherapeutics Inc|IFRX - Full Business Value|Enterprise Value XFOR|Total Enterprise Value Adicet Bio, Inc.|CELU (Celularity Inc) - Real Price to Acquire Entire Company|Enterprise Value INmune Bio Corporation (INMB)|Real Price to Acquire Entire Company Barinthus Biotherapeutics|Aggregate Business Value kezarlifesciences.com (KZR)|Enterprise Value SABS|Company Buyout Price Akari Therapeutics PLC AKTX|ENLV: Enterprise Value|QTTB: Real Price to Acquire Entire Company|GeoVax Labs, Inc. - Total Company Value|Company Buyout Price edesabiotech.com|IBIO - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Carisma Tx|XTLB (XTL Biopharmaceuticals, Ltd.) - Enterprise Value|Company Buyout Price BOLT (boltbio.com)|HCWB - Total Company Value|Business Value Aptevo Therapeutics, Inc. APVO|AIM: Enterprise Value|Aditxt (ADTX) - Real Price to Acquire Entire Company|GRI Bio Corp - Real Price to Acquire Entire Company|XRTX (XORTX Corp) - Company Buyout Price|HIND - Total Company Value|Value Adjusted for Debt and Cash revbiosciences.com|Enterprise Value INDP|Enterprise Value SCNI (Scinai Immunotherapeutics Ltd)|CalciMedica (CALI) - Total Company Value|AFMD - Full Business Value|Real Price to Acquire Entire Company Allakos Therapeutics ALLK|HOOK: Aggregate Business Value|Total Company Value igmbio.com (IGMS)|iTeos Therapeutics Inc (ITOS) - Full Business Value|OCEA - Enterprise Value|Value Adjusted for Debt and Cash TC BioPharm Ltd|Enterprise Value THRD